Stay updated on Pembrolizumab in Neoplasms Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Neoplasms Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:28.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Site version updated from v3.4.3 to v3.5.0. No visible changes to the study details, eligibility criteria, or other study content.
    Difference
    0.1%
    Check dated 2026-03-19T04:55:41.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.4.3 now shown, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:51:57.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Minor metadata updates were made, including a revision tag (v3.4.2) and update dates (2026-02-10, 2026-01-29, 2026-01). The government funding lapse notice was removed.
    Difference
    0.6%
    Check dated 2026-02-11T14:30:31.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and updated the revision to v3.4.1 (removing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:31:09.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Glossary display added; QC metadata updated to show Last Update Submitted that Met QC Criteria and Last Update Posted, with old QC labels replaced and Revision updated to v3.4.0.
    Difference
    0.3%
    Check dated 2026-01-28T06:13:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Neoplasms Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.